On April 13th, 2021, US health officials paused the use of the Johnson & Johnson vaccine. The decision to pause the injection of the vaccine was after six women reported having a rare blood-clotting disorder after receiving the vaccine.
The Food and Drug Administration(FDA) said that the six women aged between 18 and 48 developed blood clots after 6 to 13 days of being vaccinated. The officials further added that the review would not take long and would be over in a matter of days.
Over 6.8 million people have received the vaccine and are urged not to panic since the blood-clotting disorder is an extremely rare case.
Johnson & Johnson acknowledged that few people had developed the extremely rare condition of having their blood clot out of the vast population that received their vaccine. The company said that it is working with medical experts and health officials and will convey any updates on the “vaccine cause of blood clots” to healthcare providers and the public.
Since the reporting of the blood clot cases, Anne Schuchat, the Principal Deputy Director of the Centers for Disease Control and Prevention (CDC) has urged people who have recently received the Johnson & Johnson vaccine to be aware of sudden abdominal pain, severe headaches, or shortness of breath. The symptoms were reported by one woman who developed blood clots.